_(7944688650).jpg){kind=link}
- Published
- Updated
Withdrawal from a trial does not automatically explain the status of an open safety event. Equally, a need for follow-up does not grant unlimited authority to contact someone. Teams should assess the scope of withdrawal, applicable permissions and local requirements with authorised personnel before defining outstanding tasks.
Scope of the decision
Stopping treatment, declining visits and withdrawing permission for particular data collection may be different situations. Explain the distinction using source information. Consider follow-up together with medical assessment and appropriate local requirements; a general operational example cannot itself provide a legal or clinical decision.
Worked review
Suppose a participant stops attending study visits while the permitted scope of follow-up for a serious event remains unclear. The team neither automatically closes the record nor starts unauthorised calls. The investigator and relevant specialists assess the situation, recording permitted follow-up, unavailable activities and remaining uncertainty.
Practical checks
- Explain from the source which activities and communications the withdrawal covers.
- Connect medical and operational ownership of follow-up for the open event.
- Record honestly when information cannot be obtained or collection is not permitted.
Acceptance and limits
Acceptance requires a follow-up status grounded in authorised assessment and actual communication boundaries. Do not fill missing information with an assumption that the outcome improved. Keep visible how relevant records and assessments will be updated if further information arrives.
Frequently asked questions
- Does withdrawal mean that the event is closed?
- No. Participation status and the known event outcome are separate fields and assessments.
- May every withdrawn participant be contacted again?
- Do not assume this universally; permissions, local rules and authorised assessment determine the appropriate approach.